Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.
TaschenbuchKartoniert, Paperback
256 Seiten
Englisch
Orion Publishing Coerschienen am12.09.2024
Bio-tech has arrived. It could pave the way to a greater future for humanity. It could also tear the human race apart. One woman may have to make that decision on her own...mehr

Produkt

KlappentextBio-tech has arrived. It could pave the way to a greater future for humanity. It could also tear the human race apart. One woman may have to make that decision on her own...
Details
ISBN/GTIN978-1-4732-0332-7
ProduktartTaschenbuch
EinbandartKartoniert, Paperback
Erscheinungsjahr2024
Erscheinungsdatum12.09.2024
Seiten256 Seiten
SpracheEnglisch
MasseBreite 233 mm, Höhe 152 mm, Dicke 20 mm
Gewicht314 g
Artikel-Nr.60572794
Rubriken
GenreSF/Fantasy TB

Autor

Hannu Rajaniemi was born in Finland. At the age of eight he approached the European Space Agency with a fusion-powered spaceship design, which was received with a polite "thank you" note. Hannu studied mathematics and theoretical physics at University of Oulu and Cambridge and holds a PhD in string theory from the University of Edinburgh. He co-founded a mathematics consultancy whose clients included UK Ministry of Defence and the European Space Agency.

Hannu is the author of four novels including The Quantum Thief (winner of 2012 Tähtivaeltaja Award for the best science fiction novel published in Finland and translated into more than 20 languages). His most recent book is Summerland (June 2018), an alternate history spy thriller in a world where the afterlife is real. His other works include Invisible Planets: Collected Fiction, a short story collection.

Hannu lives in the San Francisco Bay Area. He is a co-founder and CEO of HelixNano, a venture- and Y Combinator backed biotech startup.